Section Arrow
MCRB.NASDAQ
- Seres Therapeutics
(Financial Status)
Quotes are at least 15-min delayed:2024/05/18 23:02 EDT
Last
 0.9199
-0.0045 (-0.49%)
Day High 
0.9985 
Prev. Close
0.9244 
1-M High
1.28 
Volume 
2.01M 
Bid
0.9
Ask
0.929
Day Low
0.901 
Open
0.94 
1-M Low
0.54 
Market Cap 
140.00M 
Currency USD 
P/E -- 
%Yield
10-SMA
20-SMA 0.92 
50-SMA 0.82 
52-W High 6.26 
52-W Low 0.54 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.59/-0.81
Enterprise Value
347.26M
Balance Sheet
Book Value Per Share
-0.39
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
126.33M
Operating Revenue Per Share
0.84
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NBYNovaBay Pharmaceuticals0.1186-0.0014-1.17%-- 
SCPXScorpius Holdings0.1035+0.0034+3.40%-- 
JAGXJaguar Health0.2585-0.0282-9.84%-- 
DNAGinkgo Bioworks Holdings0.8056-0.0334-3.98%-- 
ONCOOnconetix0.156+0.015+10.64%-- 
Quotes are at least 15-min delayed:2024/05/18 23:02 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by thecompany are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.